Latest News about Cannabis
Recent news which mentions Cannabis
CBD Drug For Tuberous Sclerosis: Caregivers Continue Epidiolex Treatment Citing Seizure Reduction And Cognitive Improvements
December 09, 2024
From Benzinga
EXCLUSIVE: Drug Expert Dr. Carl Hart Slams Cannabis Prohibition Amid Hemp-THC Surge
December 09, 2024
From Benzinga
Only 3% Of Cannabis Consumed In Canada Came From Illicit Sources, National Survey Shows
December 09, 2024
Tickers
NEWS
From Benzinga
War On Drugs 'Has Failed, Completely And Utterly': UN High Commissioner Urges Evidence-Based Solutions
December 09, 2024
From Benzinga
85% Of Cannabis Companies Report Positive Earnings, But Not All Are Winning - See Who's Leading
December 09, 2024
From Benzinga
Canopy Growth Wraps Up Acreage Acquisition Expanding US Cannabis Portfolio, What Investors Need To Know
December 09, 2024
From Benzinga
Why Cannabis Sales Are Down In Massachusetts And New Mexico: The Numbers Behind The Dip
December 08, 2024
From Benzinga
NY Certifies 1,100 Cannabis Workers Amid Equity Program Concerns
December 08, 2024
From Benzinga
Why Kentucky Is Keeping Marijuana Applicants' Names A Secret
December 06, 2024
Tickers
NEWS
From Benzinga
New York Medical Cannabis Industry Challenges The State's System: $20M Fee Per Operator At Stake
December 06, 2024
Tickers
NEWS
From Benzinga
DeSantis, Trump Mend Fences After Florida Cannabis Split While Pete Hegseth Scandal Deepens
December 06, 2024
Tickers
NEWS
From Benzinga
[VIDEO] Watch Cannabis Farm Rattled By California's 7.0 Earthquake
December 06, 2024
Tickers
NEWS
From Benzinga
Organigram Wants To Become Canada's Largest Cannabis Company By Market Share Via $71M Acquisition Deal
December 06, 2024
From Benzinga
DEA's Cannabis Rescheduling Hearing Set To Begin In January 2025 As Controversy Mounts
December 06, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.